CXCR4 and B-cell chronic lymphocytic leukemia: For example, the fully human IgG4 anti-CXCR4 mAb ulocuplumab induces the death of primary CLL cells in vitro through a reactive oxygen-species-dependent pathway [207] (Table 2).